Ziovir-TLD HIV Products Manufacturer in India
Access to appropriately manufactured antiretroviral medicines is an important part of modern HIV care. As healthcare providers, pharmaceutical distributors, institutional buyers, and international pharmaceutical businesses look for consistent medicine supply, the role of experienced pharmaceutical companies has become increasingly important. Ziovir-TLD HIV Products Manufacturer is a relevant search term for buyers looking for pharmaceutical companies associated with the manufacturing and supply of Tenofovir Disoproxil Fumarate, Lamivudine, and Dolutegravir combinations.
Sunrise Remedies is engaged in pharmaceutical product manufacturing and supply, serving healthcare and pharmaceutical markets with a focus on product quality, regulatory requirements, and organized order processing. Ziovir-TLD contains a combination of Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg, and Dolutegravir 50 mg.
This article explains the product composition, the role of its active ingredients, important points about pharmaceutical sourcing, and how buyers can communicate with Sunrise Remedies for product-related requirements.
Understanding Ziovir-TLD
Ziovir-TLD is a fixed-dose antiretroviral combination containing three active pharmaceutical ingredients:
Tenofovir Disoproxil Fumarate 300 mg
Lamivudine 300 mg
Dolutegravir 50 mg
These medicines belong to different antiretroviral classes and are combined into a single formulation. Fixed-dose combinations can simplify medicine administration by bringing multiple active ingredients together in one dosage form.
The combination is associated with antiretroviral treatment programs and is intended to be used under appropriate medical supervision. Patients should use HIV medicines only according to the treatment plan provided by a qualified healthcare professional.
Role of Tenofovir Disoproxil Fumarate
Tenofovir Disoproxil Fumarate, commonly abbreviated as TDF, is a nucleotide reverse transcriptase inhibitor. It is used as part of combination antiretroviral therapy for HIV management.
In a pharmaceutical formulation such as Ziovir-TLD, the 300 mg strength contributes to the overall antiretroviral combination. Tenofovir works by interfering with the activity of HIV reverse transcriptase, an enzyme involved in viral replication.
For pharmaceutical buyers, the presence of a clearly specified active ingredient and strength is an important part of product identification. Manufacturing, packaging, documentation, and quality-control processes should correspond with applicable pharmaceutical requirements.
Understanding Lamivudine 300 mg
Lamivudine is another antiretroviral medicine used in combination treatment for HIV. It belongs to the nucleoside reverse transcriptase inhibitor class.
The Ziovir-TLD formulation contains Lamivudine 300 mg. When used in combination with other antiretroviral medicines, Lamivudine contributes to suppression of HIV replication.
From a pharmaceutical sourcing perspective, buyers should pay attention to the declared composition, dosage strength, packaging specifications, batch information, and applicable documentation when evaluating antiretroviral products.
Role of Dolutegravir 50 mg
Dolutegravir is an integrase strand transfer inhibitor, commonly referred to as an integrase inhibitor. It works by targeting HIV integrase, an enzyme required for the virus to incorporate its genetic material into human cells.
Ziovir-TLD contains Dolutegravir 50 mg alongside Tenofovir Disoproxil Fumarate and Lamivudine.
The combination of medicines with different mechanisms of action is an important feature of modern antiretroviral therapy. The specific treatment regimen, suitability, dosage, and duration should always be determined by a qualified healthcare professional.
Why Fixed-Dose Combinations Matter
Fixed-dose combination medicines can offer practical advantages in treatment programs because multiple active pharmaceutical ingredients are incorporated into one formulation.
For healthcare systems and pharmaceutical distribution networks, simplified formulations may support easier inventory management and dispensing. For patients, a combination formulation may reduce the number of separate tablets required as part of a prescribed regimen.
However, pharmaceutical products should not be selected solely on convenience. Product specifications, regulatory status, manufacturing standards, documentation, storage requirements, and market-specific requirements are all important considerations.
Pharmaceutical Manufacturing and Product Consistency
The manufacturing of antiretroviral medicines requires controlled processes throughout production. Pharmaceutical companies need to manage raw materials, formulation processes, quality checks, packaging, storage, and documentation systematically.
For a product such as Ziovir-TLD, consistency in the stated composition is particularly important. Each active ingredient must correspond to the declared strength and product specifications.
Quality management may involve several stages, including raw-material evaluation, production controls, in-process checks, finished-product testing, packaging inspection, and batch documentation.
Sunrise Remedies focuses on organized pharmaceutical manufacturing and supply processes for healthcare products and supports business requirements related to pharmaceutical product sourcing.
Ziovir-TLD for Pharmaceutical Distribution
Distributors and pharmaceutical businesses may require antiretroviral products for different market channels. These can include domestic pharmaceutical networks, institutional procurement, healthcare distributors, and international business requirements where permitted.
When sourcing Ziovir-TLD, commercial buyers may need information such as:
Product name and composition
Available pack configuration
Batch and manufacturing information
Product documentation
Storage requirements
Order quantity
Delivery location
Applicable market requirements
The exact documentation and commercial requirements can differ depending on the destination market and the nature of the buyer.
Importance of Proper Product Storage
Pharmaceutical product quality depends not only on manufacturing but also on appropriate handling after production. Storage conditions should follow the product's approved specifications and packaging information.
Distributors and healthcare organizations should maintain suitable storage environments, protect pharmaceutical products from inappropriate exposure, and follow inventory-management procedures.
Good stock rotation practices can also help businesses manage pharmaceutical inventory efficiently. Buyers should review the product documentation and packaging instructions supplied for the specific product before establishing storage procedures.
Documentation and Order Communication
Clear communication between pharmaceutical suppliers and buyers can reduce errors during the procurement process. Buyers looking for Ziovir -TLD HIV Products Manufacturer should provide complete information about their requirements.
Useful details may include the required quantity, destination country or city, preferred packaging, business type, regulatory requirements, and expected delivery schedule.
Sunrise Remedies can be contacted for product-related discussions, commercial inquiries, and pharmaceutical sourcing requirements. Providing complete order information allows the supplier to understand the buyer's requirements more accurately.
Market Requirements for Antiretroviral Products
Antiretroviral products can be subject to different regulatory and documentation requirements depending on the country where they are supplied. International buyers should therefore evaluate the requirements applicable to their specific market before placing an order.
Import regulations, product registration, labeling requirements, documentation, customs procedures, and pharmaceutical licensing requirements may vary between countries.
For this reason, buyers should communicate their destination-market requirements clearly during the inquiry stage. This helps establish whether the requested product and documentation are appropriate for the intended market.
Sunrise Remedies and Ziovir-TLD Product Inquiries
Sunrise Remedies provides pharmaceutical manufacturing and supply services for healthcare-focused product requirements. Buyers searching for Ziovir-TLD HIV Products Manufacturer in India can contact the company to discuss product specifications and business requirements.
The company can assist interested pharmaceutical businesses with information related to product composition, availability, packaging, order requirements, and supply discussions.
Key Points About Ziovir-TLD
Ziovir-TLD is a three-drug fixed-dose antiretroviral combination containing Tenofovir Disoproxil Fumarate, Lamivudine, and Dolutegravir.
The formulation includes:
Tenofovir Disoproxil Fumarate 300 mg + Lamivudine 300 mg + Dolutegravir 50 mg
Each ingredient contributes a specific antiretroviral mechanism to the combination. The product is intended for use within appropriate HIV treatment programs and should be used according to professional medical guidance.
For pharmaceutical businesses, understanding the composition is only one part of the procurement process. Product specifications, manufacturing information, documentation, packaging, storage, regulatory considerations, and commercial terms should also be evaluated.
Final Thoughts
The demand for appropriately manufactured antiretroviral products makes pharmaceutical manufacturing and supply capabilities an important part of the healthcare ecosystem. Ziovir-TLD combines three established antiretroviral ingredients—Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg, and Dolutegravir 50 mg—in a fixed-dose formulation.
For businesses searching for a Ziovir -TLD HIV Products Manufacturer, Sunrise Remedies offers a point of contact for pharmaceutical product and supply inquiries. Buyers can communicate their specific requirements, destination market, quantity, and documentation needs to begin a product discussion.
Sunrise Remedies
Phone: +91 7575043215
Email: info@sunriseremedies.in
Comments